EGFR and non-small cell lung carcinoma: In this study, we evaluated the SQI parameter from the cobas® EGFR Test as a measure for the number of mutated copies/mL and for the VAF of mutant EGFR allele in plasma in advanced NSCLC patients harboring an Ex19Del of EGFR gene.